Sinopharm Group Co (SHTDY) Price & Analysis

Compare

21 Followers

SHTDY Stock Chart & Stats

Day’s Range― - ―

52-Week Range$10.30 - $15.16

Previous CloseN/A

Volume2.10K

Average Volume (3M)906.00

Market Cap

$7.48B

Enterprise Value$25.34B

Total Cash (Recent Filing)$54.31B

Total Debt (Recent Filing)$76.39B

Price to Earnings (P/E)7.9

Beta0.29

Next Earnings

Nov 03, 2025

EPS EstimateN/A

Last Dividend Ex-Date

Jun 17, 2025

Dividend Yield3.96%

Share Statistics

EPS (TTM)0.77

Shares Outstanding268,362,150

10 Day Avg. Volume641

30 Day Avg. Volume906

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap3.39

Enterprise Value/Revenue0.04

Enterprise Value/Gross Profit0.57

Enterprise Value/Ebitda1.26

Forecast

1Y Price Target

$13.50

Price Target Upside13.26% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Sinopharm Group Co News

Sinopharm Group Reports Decline in Interim Earnings

Sinopharm Group Co., Ltd. Unsponsored ADR Class H ( ($SHTDY) ) has released its Q2 earnings. Here is...

17d ago

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Morgan Stanley analyst Laurence Tam maintained a Buy rating on Sinopharm Group Co today and set a price...

19d ago

Sinopharm Group Reports Stable Earnings Amid Revenue Dip

Sinopharm Group Co., Ltd. Unsponsored ADR Class H ( ($SHTDY) ) has released its Q1 earnings. Here is...

4M ago

Sinopharm Group Reports Decline in 2024 Earnings

Sinopharm Group Co., Ltd. Unsponsored ADR Class H ( ($SHTDY) ) has released its Q4 earnings. Here is...

6M ago

Sinopharm Group Reports Mixed Financial Results

Sinopharm Group Co., Ltd. Unsponsored ADR Class H ( ($SHTDY) ) has released its Q3 earnings. Here is...

10M ago

Sinopharm Group Co (SHTDY) Announces Q2 Dividend: Save the Dates!

Sinopharm Group Co (Other OTC: SHTDY) has declared, under its dividend policy, a yearly cash dividend in the...

1y ago

SHTDY FAQ

What was Sinopharm Group Co’s price range in the past 12 months?

Sinopharm Group Co lowest stock price was $10.30 and its highest was $15.16 in the past 12 months.

What is Sinopharm Group Co’s market cap?

Sinopharm Group Co’s market cap is $7.48B.

When is Sinopharm Group Co’s upcoming earnings report date?

Sinopharm Group Co’s upcoming earnings report date is Nov 03, 2025 which is in 54 days.

How were Sinopharm Group Co’s earnings last quarter?

Sinopharm Group Co released its earnings results on Aug 22, 2025. The company reported $0.765 earnings per share for the quarter, beating the consensus estimate of N/A by $0.765.

Is Sinopharm Group Co overvalued?

According to Wall Street analysts Sinopharm Group Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Sinopharm Group Co pay dividends?

Sinopharm Group Co pays a Annually dividend of $0.471 which represents an annual dividend yield of 3.96%. See more information on Sinopharm Group Co dividends here

What is Sinopharm Group Co’s EPS estimate?

Sinopharm Group Co’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sinopharm Group Co have?

Sinopharm Group Co has 268,362,150 shares outstanding.

What happened to Sinopharm Group Co’s price movement after its last earnings report?

Sinopharm Group Co reported an EPS of $0.765 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.715%.

Which hedge fund is a major shareholder of Sinopharm Group Co?

Currently, no hedge funds are holding shares in SHTDY

Sinopharm Group Co Stock Smart Score

Neutral

Fundamentals

Return on Equity

8.74%

Trailing 12-Months

Asset Growth

-0.78%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Sinopharm Group Co

Sinopharm Group Co., Ltd. is a leading healthcare and pharmaceutical company based in China, primarily engaged in the distribution of pharmaceuticals, medical devices, and healthcare products. The company operates through various sectors, including pharmaceutical distribution, retail pharmacy, and healthcare services. Sinopharm also invests in research and development, focusing on innovative drug development and biotechnology. Its core products include a wide range of medicines, vaccines, and medical equipment, catering to both domestic and international markets.

Sinopharm Group Co (SHTDY) Earnings & Revenues

Historic Earnings Reports

SHTDY Stock 12 Month Forecast

Average Price Target

$13.50

▲(13.26% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","11":"$11","12":"$12","13":"$13","14":"$14"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":13.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$13.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,11,12,13,14],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2020","6":"Dec<br/>2020","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.115384615384615,12.23076923076923,12.346153846153847,12.461538461538462,12.576923076923077,12.692307692307692,12.807692307692308,12.923076923076923,13.038461538461538,13.153846153846153,13.26923076923077,13.384615384615385,{"y":13.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.115384615384615,12.23076923076923,12.346153846153847,12.461538461538462,12.576923076923077,12.692307692307692,12.807692307692308,12.923076923076923,13.038461538461538,13.153846153846153,13.26923076923077,13.384615384615385,{"y":13.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.115384615384615,12.23076923076923,12.346153846153847,12.461538461538462,12.576923076923077,12.692307692307692,12.807692307692308,12.923076923076923,13.038461538461538,13.153846153846153,13.26923076923077,13.384615384615385,{"y":13.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.21,"date":1572566400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.21,"date":1575158400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.21,"date":1577836800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.21,"date":1580515200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.21,"date":1583020800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.21,"date":1583020800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.21,"date":1606780800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.3,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.21,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >